<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Healthcare Sector on FinanClub</title>
    <link>https://finan.club/tags/healthcare-sector/</link>
    <description>Recent content in Healthcare Sector on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 08 Aug 2023 05:48:00 +0000</lastBuildDate><atom:link href="https://finan.club/tags/healthcare-sector/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title> PFE</title>
      <link>https://finan.club/us/pfe/</link>
      <pubDate>Tue, 08 Aug 2023 05:48:00 +0000</pubDate>
      
      <guid>https://finan.club/us/pfe/</guid>
      <description>score:953
Chances: BioNTech, Pfizer&amp;rsquo;s partner, is still on track with its &amp;lsquo;variant-adapted Covid-19 vaccine&amp;rsquo; despite a drop in sales during the second quarter. Pfizer&amp;rsquo;s CEO is focusing on new drug approvals and deals to drive growth after the pandemic-related boost from Covid-19 vaccine and drug sales.</description>
    </item>
    
  </channel>
</rss>
